Human Apolipoprotein E / APOE3 Protein, premium grade

Customer Reviews
Cat. No. / Size
Price
Qty
APE-H5318-50ug
$285.00
APE-H5318-100ug
$408.00
APE-H5318-1mg (50ug X 20)
$2000.00
ETA of in-stock products:2 business days

Product Details

  • Features and Advantages

    1. Seamless Transition from Preclinical to Clinical: Same cell clone, process, and QC as GMP products.
    2. Enhanced Production Standards: AOF raw materials, pharma-grade excipients, Grade B+A (ISO 5) environment.
    3. Comprehensive Quality Control: Additional strict testing for process impurities, sterility, and mycoplasma.
    4. Cost-Effective Solution: GMP-comparable quality at an economical price for early development.
    5. Risk Mitigation: Enhanced safety through rigorous impurity control and comprehensive testing.
  • Synonyms

    Apolipoprotein E, APOE, Apo-E

  • Source

    Human APOE3 Protein, premium grade (APE-H5318) is expressed from CHO cells. It contains AA Lys 19 - His 317 (Accession # P02649-1 ).

    Predicted N-terminus: Lys 19

    It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage. When ready to transition into later clinical phases, we also offer a custom GMP protein service that tailors to your needs. We will work with you to customize and develop a GMP-grade product in accordance with your requests that also meets the requirements for raw and ancillary materials use in cell manufacturing of cell-based therapies.

    Request for sequence
  • Molecular Characterization

    Apolipoprotein E Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries no "tag".

    The protein has a calculated MW of 34.2 kDa. The protein migrates as 37 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Host Cell Protein

    <0.5 ng/µg of protein tested by ELISA.

  • Host Cell DNA

    <0.001 ng/μg of protein tested by qPCR.

  • Sterility

    Negative

  • Mycoplasma

    Negative

  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 20 mM MOPS, 150 mM NaCl, pH7.3 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Shipping and Storage

    This product is shipped at ambient temperature.

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process
  • Quality Description

    ACRO's Research-grade products are suitable for a wide range of cell culture applications, particularly for research use in academic institutions. These products are sterilized by filtration, followed by lyophilization where applicable. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. Biological activity is calibrated against WHO/NIBSC standards when available.
    ACRO's Premium-grade (Pre-GMP) products are characterized by their high quality and enhanced safety profiles, making them ideal for early-stage discovery and manufacturing processes in cell therapy companies. A key advantage is their seamless transition to corresponding GMP-grade versions. Biological activity is calibrated against WHO/NIBSC standards when available. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. In addition, rigorous testing is conducted to ensure the absence of mycoplasma, HCD, and HCP, thereby guaranteeing product safety.

Customers Also Viewed

Performance Data

  • SDS-PAGE

    Apolipoprotein E SDS-PAGE

    Human APOE3 Protein, premium grade on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • Bioactivity-ELISA

     Apolipoprotein E ELISA

    Immobilized Human APOE3 Protein, premium grade (Cat. No. APE-H5318) at 5 μg/mL (100 μL/well) can bind Human LDL R, Fc Tag (Cat. No. LDR-H5251) with a linear range of 0.078-2.5 μg/mL (Routinely tested).

    Protocol
  •  Apolipoprotein E ELISA

    Immobilized Human APOE3 Protein, premium grade (Cat. No. APE-H5318) at 5 μg/mL (100 μL/well) can bind Human VLDL R, His Tag (Cat. No. VLR-H5227) with a linear range of 0.078-1.25 μg/mL (Routinely tested).

    Protocol
  • Bioactivity-SPR

     Apolipoprotein E SPR

    Human VLDL R, His Tag (Cat. No. VLR-H5227) immobilized on CM5 Chip can bind Human APOE3 Protein, premium grade (Cat. No. APE-H5318) with an affinity constant of 6.94 nM as determined in a SPR assay (Biacore8K) (QC tested).

    Protocol

Customer Reviews
Writing Reviews

Background

APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density lipoproteins (IDL) but shows a preferential binding to high-density lipoproteins (HDL). It also binds a wide range of cellular receptors including the LDL receptor/LDLR, the LDL receptor-related proteins LRP1, LRP2 and LRP8 and the very low-density lipoprotein receptor/VLDLR that mediate the cellular uptake of the APOE-containing lipoprotein particles.

Recent Advances

 
Drug Development Progress
  • English Name:

    Apolipoprotein E

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    3 Details

  • Highest Development Stage:

    Phase 2 Clinical

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8